NEW YORK, Oct. 31, 2016 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Spectrum Pharmaceuticals, Inc. (“Spectrum Pharmaceuticals”) (NASDAQ:SPPI) between December 16, 2015 and September 16, 2016.
You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the District of Nevada. If you purchased or otherwise acquired Spectrum Pharmaceuticals between December 16, 2015 and September 16, 2016, your rights may be affected by this action. To get more information go to:
http://www.zlk.com/pslra/spectrum-pharmaceuticals-inc
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The Complaint alleges that throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Food and Drug Administration (the "FDA") questioned whether the data from the 611 and 612 Studies were clinically significant; (2) the FDA informed defendants in December 2012 not to submit the New Drug Application based on data from the 611 and 612 Studies; and (3) accordingly, defendants' public statements concerning the Company's business, operations and prospects were materially false and misleading at all relevant times.
If you suffered a loss in Spectrum Pharmaceuticals you have until November 21, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


SpaceX Targets Record-Breaking $75 Billion IPO at $135 Per Share in Historic Market Debut
Palo Alto Networks Q3 FY2026 Earnings Surge on Strong AI Security Demand, Raises Full-Year Outlook
Quantinuum Raises $1.68 Billion in Upsized Nasdaq IPO Amid Growing Quantum Computing Demand
CBS News Fires Scott Pelley Amid Major Changes at ‘60 Minutes’ in 2026
DeepSeek Targets $7.4 Billion Funding Round, Valuation Could Reach $59 Billion in 2026
TSMC Sees Strong AI-Driven Growth as Demand for Advanced Chips Continues to Surge
Meta Delays Release of New AI Model as API Rollout Remains Uncertain
Ryan Kavanaugh and Acme AI & FX Bets on Artificial Intelligence to Reinvent Film Production Economics
Jensen Huang Strengthens Nvidia’s South Korea Ties Amid AI Expansion
US Expands Iran Sanctions, Targets Major Crypto Exchanges and Individuals
Treasury Wine Estates to Focus on Penfolds and Key Brands in Major Cost-Cutting Overhaul
Bayer Rules Out Monsanto Spin-Off as Roundup Lawsuits Continue to Mount
Hyundai, Nvidia, and South Korea Near Deal for Major AI Technology Center
Honeywell Aerospace Targets $6.5 Billion Earnings by 2030 After Spin-Off
Foreign Firms Cash In on India's IPO Boom
SpaceX Sets IPO Price at $135 Per Share Ahead of Historic Nasdaq Debut 



